Denmark vs Oman: Hepatitis B surface antigen (HBsAg) prevalence
Denmark
0.1%
in 2024
Oman
0.1%
in 2024
Denmark rank
101st
Oman rank
101st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Denmark
- Oman
How they compare
Denmark currently reports 0.1% against 0.1% in Oman, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Denmark ahead.
Denmark ranks 101st and Oman ranks 101st of 194 countries.
Denmark has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Denmark | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | Denmark |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Denmark or Oman?
- Denmark, at 0.1% against 0.1% in Oman as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Denmark and Oman?
- 0.0%, with Denmark ahead.
- How many years of comparable data are there for Denmark and Oman?
- 10 years are reported by both, from 2015 to 2024.
- How do Denmark and Oman rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Denmark ranks 101st and Oman ranks 101st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.